Adaptive Biotechnologies Corporation
US ˙ NasdaqGS ˙ US00650F1093

SecurityADPT / Adaptive Biotechnologies Corporation
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership86 shares
Latest Disclosed Value $ 1,193
Simplex Trading, Llc ownership in ADPT / Adaptive Biotechnologies Corporation

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 86 shares of Adaptive Biotechnologies Corporation (US:ADPT) valued at $1,194 USD as of March 31, 2026. The entity filed a previous 13F-HR on August 5, 2025 disclosing 0 shares of Adaptive Biotechnologies Corporation. The current value of the position is $1,375 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (ADPT) in the form of stock options. The firm currently holds call options representing 900 of underlying shares valued at $12,492 USD and put options representing 300 of underlying shares valued at $4,164 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ADPT / Adaptive Biotechnologies Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 86 86 1 0.0000
2025-08-05 2025-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 0 -963 -100.00 0 0.0000
2025-05-12 2025-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 963 882 1,088.89 0 0.0000
2025-02-11 2024-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 81 -2,821 -97.21 0 0.0000
2024-11-08 2024-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 2,902 -20,391 -87.54 0 0.0000
2024-07-25 2024-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 23,293 -4,873 -17.30 0 0.0001
2024-04-25 2024-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 28,166 25,599 997.23 0 0.0001
2024-02-02 2023-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 2,567 2,567 0 0.0000
2023-11-01 2023-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 0 -10,075 -100.00 0 0.0000
2023-08-04 2023-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 10,075 6,597 189.68 0 0.0001
2023-04-27 2023-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 3,478 1,525 78.08 0 0.0000
2023-02-02 2022-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,953 866 79.67 0 -100.00 0.0000
2022-11-04 2022-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,087 1,087 7 0.0000
2022-08-03 2022-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 0 -4,135 -100.00 0 -100.00
2022-05-02 2022-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 4,135 3,232 357.92 57 128.00 0.0001
2022-02-23 2021-12-31 13F/A-1 ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 903 210 30.30 25 -7.41 0.0000
2022-02-04 2021-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 693 0 27 0.0000
2021-10-28 2021-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 693 400 136.52 27 145.45 0.0000
2021-08-12 2021-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 293 -8,766 -96.77 11 -96.98 0.0000
2021-04-26 2021-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 9,059 9,059 2,991.81 364 3,209.09 0.0007
2020-04-28 2020-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 0 -783 -100.00 0 -100.00
2020-02-05 2019-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 783 783 23 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 900 12 n/a n/a n/a
2026-02-11 2025-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 0 -100.00 0 n/a n/a n/a
2025-11-12 2025-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 18,100 -44.98 0 n/a n/a n/a
2025-08-05 2025-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 32,900 498.18 0 n/a n/a n/a
2025-05-12 2025-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 5,500 511.11 0 n/a n/a n/a
2025-02-11 2024-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 900 -10.00 0 n/a n/a n/a
2024-11-08 2024-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 1,000 900.00 0 n/a n/a n/a
2024-07-25 2024-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 100 0 n/a n/a n/a
2024-04-25 2024-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 0 -100.00 0 n/a n/a n/a
2024-02-02 2023-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 8,100 -51.79 0 n/a n/a n/a
2023-11-01 2023-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 16,800 64.71 0 n/a n/a n/a
2023-08-04 2023-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 10,200 -41.38 0 n/a n/a n/a
2023-04-27 2023-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 17,400 109.64 0 n/a n/a n/a
2023-02-02 2022-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 8,300 -65.56 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 24,100 -44.60 171 -51.28 n/a n/a n/a
2022-08-03 2022-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 43,500 770.00 351 408.70 n/a n/a n/a
2022-05-02 2022-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 5,000 284.62 69 91.67 n/a n/a n/a
2022-02-23 2021-12-31 13F/A ADAPTIVE BIOTECHNOLOGIES COR CALL Call 1,300 -93.69 36 -95.62 n/a n/a n/a
2022-02-04 2021-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 20,600 821 n/a n/a n/a
2021-10-28 2021-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 20,600 -0.96 821 -3.30 n/a n/a n/a
2021-08-12 2021-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 20,800 34,566.67 849 252.28 n/a n/a n/a
2021-04-26 2021-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 60 -69.70 241 -79.40 n/a n/a n/a
2021-02-02 2020-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 198 -46.34 1,170 -34.78 n/a n/a n/a
2020-10-14 2020-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 369 -4.40 1,794 -3.91 n/a n/a n/a
2020-07-13 2020-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 386 271.15 1,867 548.26 n/a n/a n/a
2020-04-29 2020-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 104 1,980.00 288 1,957.14 n/a n/a n/a
2020-02-05 2019-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 5 -99.07 14 -99.16 n/a n/a n/a
2019-10-15 2019-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR CALL Call 540 1,668 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 300 4 n/a n/a n/a
2026-02-11 2025-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 0 -100.00 0 n/a n/a n/a
2025-11-12 2025-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 700 -56.25 0 n/a n/a n/a
2025-08-05 2025-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 1,600 -30.43 0 n/a n/a n/a
2025-05-12 2025-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 2,300 0 n/a n/a n/a
2025-02-11 2024-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 0 -100.00 0 n/a n/a n/a
2024-11-08 2024-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 8,100 -75.68 0 n/a n/a n/a
2024-07-25 2024-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 33,300 -1.77 0 n/a n/a n/a
2024-04-25 2024-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 33,900 6,680.00 0 n/a n/a n/a
2024-02-02 2023-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 500 -16.67 0 n/a n/a n/a
2023-11-01 2023-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 600 -94.34 0 n/a n/a n/a
2023-08-04 2023-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 10,600 125.53 0 n/a n/a n/a
2023-04-27 2023-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 4,700 235.71 0 n/a n/a n/a
2023-02-02 2022-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 1,400 -33.33 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 2,100 -36.36 14 -46.15 n/a n/a n/a
2022-08-03 2022-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 3,300 -84.51 26 -91.19 n/a n/a n/a
2022-05-02 2022-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 21,300 634.48 295 264.20 n/a n/a n/a
2022-02-23 2021-12-31 13F/A ADAPTIVE BIOTECHNOLOGIES COR PUT Put 2,900 163.64 81 88.37 n/a n/a n/a
2022-02-04 2021-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 1,100 43 n/a n/a n/a
2021-10-28 2021-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 1,100 0.00 43 -2.27 n/a n/a n/a
2021-08-12 2021-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 1,100 348.98 44 -95.54 n/a n/a n/a
2021-04-26 2021-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 245 8,066.67 986 5,700.00 n/a n/a n/a
2021-02-02 2020-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 3 -95.45 17 -94.69 n/a n/a n/a
2020-10-14 2020-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 66 -63.93 320 -63.84 n/a n/a n/a
2020-07-13 2020-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 183 1,933.33 885 3,440.00 n/a n/a n/a
2020-04-29 2020-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 9 0.00 25 -3.85 n/a n/a n/a
2020-02-05 2019-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 9 -62.50 26 -64.86 n/a n/a n/a
2019-10-15 2019-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR PUT Put 24 74 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.